Old Web
English
Sign In
Acemap
>
authorDetail
>
Javier Ruiz-Guiñazú
Javier Ruiz-Guiñazú
Janssen Pharmaceutica
Medicine
Pneumococcal conjugate vaccine
Serotype
Haemophilus influenzae
Clinical trial
3
Papers
8
Citations
0
KQI
Citation Trend
Filter By
Interval:
1900~2024
1900
2024
Author
Papers (3)
Sort By
Default
Most Recent
Most Early
Most Citation
No data
Journal
Conference
Others
Durability of antibody responses elicited by a single dose of Ad26.COV2.S and substantial increase following late boosting
2021
medRxiv
Jerald C. Sadoff
Mathieu Le Gars
Vicky Cardenas
Georgi Shukarev
Nathalie Vaissiere
Dirk Heerwegh
Carla Truyers
Anne Marit de Groot
Gert Scheper
Jenny Hendriks
Javier Ruiz-Guiñazú
Frank Struyf
Johan Van Hoof
Macaya Douoguih
Hanneke Schuitemaker
Show All
Source
Cite
Save
Citations (8)
Can two different pneumococcal conjugate vaccines be used to complete the infant vaccination series? A randomized trial exploring interchangeability of the 13-valent pneumococcal conjugate vaccine and the pneumococcal non-typeable Haemophilus influenzae protein D-conjugate vaccine.
2020
Expert Review of Vaccines
Abiel Mascareñas de Los Santos
Miguel Angel Rodríguez Weber
Pedro Sánchez Márquez
Magali Traskine
Roberto Carreño Manjarrez
Maria Yolanda Cervantes-Apolinar
Ana Strezova
Javier Ruiz-Guiñazú
Eduardo Ortega-Barria
Dorota Borys
Show All
Source
Cite
Save
Citations (0)
Bacterial nasopharyngeal carriage following infant immunization with pneumococcal conjugate vaccines according to a 2+1 schedule in children in South Africa: an exploratory analysis of two clinical trials.
2020
Expert Review of Vaccines
Marta C. Nunes
Marta Moreira
Anthonet Koen
Nadia van Niekerk
Lisa Jose
Clare L. Cutland
Nancy François
Sonia Schoonbroodt
Javier Ruiz-Guiñazú
Juan Pablo Yarzábal
Dorota Borys
Lode Schuerman
Shabir A. Madhi
Show All
Source
Cite
Save
Citations (0)
1